Nancy Chiaravalloti, PhD


Nancy Chiaravalloti, PhD: Using Cognitive Rehab Tactics in Healthy Individuals

The director of Centers for Neuropsychology and Neuroscience Research, and Traumatic Brain Injury Research at Kessler Foundation discussed the use of cognitive rehabilitation techniques in healthy individuals.

Aristea S. Galanopoulou, MD, PhD


EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Stephen Hantus, MD


Stephen Hantus, MD: Acute Symptomatic Seizures

The Director of the cEEG and Epilepsy Consult Service at the Cleveland Clinic Epilepsy Center spoke about the cautious for physicians treating patients with acute symptomatic seizures.

Fernando L. Pagán, MD


Unmet Needs and Improving Diagnosis of Dyskinesia in Parkinson Disease

The expert panel reviews unmet needs in treatment and management of dyskinesia and shares advice for physicians treating patients with Parkinson disease.

Stephen Silberstein, MD


Stephen Silberstein, MD: Treating Medication Overuse Headache

The director of the Jefferson Headache Center at Jefferson University Hospital discussed the need for physicians to revisit how they treat patients with chronic migraine who have developed medication overuse headache.

Whitney J. Palmer


COVID-19 Neurological Complications More Likely in Those with Hypertension, Diabetes

Two-thirds of patients with critical results were African American, demonstrating an additional need to explore associations between ethnicity and COVID-19.

Geert Mayer, MD


Geert Mayer, MD: Safety, Efficacy of Solriamfetol for Excessive Sleepiness In Narcolepsy, OSA

Long-term maintenance of efficacy was demonstrated with solriamfetol for treatment of excessive sleepiness with narcolepsy or obstructive sleep apnea.

Anton Poteinsson, MD


Anton P. Porsteinsson, MD: Addressing Trial Design and Symptom Intervention in Alzheimer Disease

The director of the University of Rochester Alzheimer's Disease Care, Research and Education Program spoke about the need to rethink trial design and Alzheimer neuropsychiatric symptom management.

Gregory Day, MD, MSc, MSCI, FAAN


Recognizing Symptoms and Causes of Rapidly Progressive Dementia: Gregory Day, MD, MSc, MSCI, FAAN

The neurologist at Mayo Clinic in Jacksonville Florida provided perspective on his talk given at the 2023 AAN annual meeting on rapidly progressive dementia. [WATCH TIME: 6 minutes]

David Irwin, MD


David Irwin, MD: Differentiating Dementias in Living Patients

The assistant professor and cognitive neurologist at the University of Pennsylvania Frontotemporal Degeneration Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.

Kiran Maski, MD, MPH


Kiran Maski, MD, MPH: The Pediatric Sleep Disorder Treatment Landscape

The director of the Sleep Clinic at Boston Children’s Hospital discussed the lack of clinical research for pediatric sleep disorders and what the current landscape looks like.

Robert E. Shapiro, MD, PhD


Robert E. Shapiro, MD, PhD: Takeaways From Migraine Telemedicine

The professor of neurology at the University of Vermont Larner College of Medicine detailed what lessons and highlights he’s learned from shifting his migraine care to a telemedicine-based model during the COVID-19 pandemic.

Jennifer S. Sun, PhD


Therapeutic Potential of IGF-1 and MECP2 in Rett Syndrome

Research that is already underway will be necessary to confirm the safety and efficacy of this class of Rett syndrome therapies, and targeting IGF-1 may be a possibility for treating additional neurological disorders beyond Rett.

Richard Finkel, MD


Richard Finkel, MD: Goals of St. Jude Center for Experimental Neurotherapeutics

The newly appointed director for the Center for Experimental Neurotherapeutics at St. Jude Children’s Research Hospital details his personal responsibilities and the long-term goals for the new center.

Mary Rensel, MD, FAAN, ABIHM


Advocacy in Neurology: A Tool to Serve and Find Fulfillment

Acting as an advocate is meaningful to neurologists because it speaks to their inner core—or their “why.” Neurologists have the agency to make this world a better place while working as a neurologist and an advocate at many levels.

Rolf Fronczek, PhD, MD


Rolf Fronczek, PhD, MD: Cluster Headaches and Sleep

Recent work demonstrates that the anterior part of the hypothalamus is enlarged in cluster headache.

Noah Rosen, MD


Noah Rosen, MD: Evaluation of Cardiovascular Risks of Galcanezumab in Episodic, Chronic Migraine

The program director of neurology at the Zucker School of Medicine, Northwell Health, spoke about the great advances of the new CGRP medications available for the prevention of migraine.

Bruce Cree, MD, PhD, MAS, FAAN


Proven Therapies Underutilized in State of Care for NMOSD: Bruce Cree, MD, PhD, MAS, FAAN

The clinical research director of the UCSF Multiple Sclerosis Center spoke about the barriers in accessing proven therapies for NMOSD at the 2023 ACTRIMS Forum. [WATCH TIME: 3 minutes]

Laura C. Speltz, MD


Cyclic Vomiting, Incontinence in a Young Boy

An 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.

Elizabeth Felton, MD, PhD


Building Trust in the Epilepsy Clinician-Patient Relationship: Elizabeth Felton, MD, PhD

The assistant professor in the Department of Neurology at the University of Wisconsin spoke about healthcare providers establishing trust with their patients and improving health equity. [WATCH TIME: 3 minutes]

Daniel Lowenstein, MD


Daniel Lowenstein, MD: Understanding the Gut-Brain Connection in Epilepsy

The professor of neurology and executive vice chancellor and provost at the University of California, San Francisco detailed the connection between the gut microbiome and epilepsy.

Smitha Reddy, PhD


Dystrophin Pathway and Treatments Offer Hope for Patients with Duchenne Muscular Dystrophy

Gene therapy has generated excitement as a treatment or even a potential cure for inherited diseases. Among them: Duchenne muscular dystrophy.

R. Edward Hogan, MD


Jacksonian Epilepsy and the Jacksonian March: R. Edward Hogan, MD

The professor of neurology at Washington University in St. Louis, and the president of the American Epilepsy Society, shared his perspective on John Hughlings Jackson’s observations of epilepsy in the brain and how it can inform modern practice. [WATCH TIME: 5 minutes]

Lynn Kramer, MD


Lynn Kramer, MD: BAN2401 Phase IIb Clinical Study Results

This is the first large late-stage clinical trial to further support the amyloid hypothesis.

Mona Al Banna, MB BCh BAO, MSc(Res)


ISC Post-Conference Recap: What Other Early Career Attendees Should Know

Third year neurology resident Mona Al Banna, MB BCh BAO, MSc(Res) recounts her first major medical conference experience and provides guidance on how to make the most of your attendance, especially as a resident or fellow.

Richard S. Trosh, MD


Monoclonal Antibodies for Alzheimer Disease and Lecanemab’s Potential: Richard Isaacson, MD

The director of the Center for Brain Health and Alzheimer prevention clinic at FAU medicine shares his experience during the Medical Crossfire session on the Alheimer pipeline that he took part in at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 7 minutes]

Emily Splichal, DPM


Emily Splichal, DPM: Using Texture for Nerve Stimulation in the Feet

Many patients with neurologic conditions such as multiple sclerosis are faced with gait and stability issues due to their disease, but Splichal and Naboso Technology seek to address these issues via mechanoreceptor stimulation.

Rhonda Voskuhl, MD


Rhonda Voskuhl, MD: A Bedside to Bench to Bedside Approach in MS

The Professor in UCLA's Department of Neurology and Director of the UCLA MS Program stressed the importance of basing research on clinical observations, understanding them in the lab, then designing novel clincal trials.

© 2023 MJH Life Sciences

All rights reserved.